alexa Huixiao Hong | U.S. Food and Drug Administration
ISSN: 2157-7609

Journal of Drug Metabolism & Toxicology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Huixiao Hong

Huixiao Hong Huixiao Hong
Center for Bioinformatics
National Center for Toxicological Research
U.S. Food and Drug Administration
Tel. 870-543-7296

Huixiao Hong, Ph.D., is a senior Scientist at the Division of Systems Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Arkansas, USA, working on the scientific bases for regulatory application and development of genomics and biomarkers at the FDA. Before he joined the FDA, he was a senior Bioinformatician and the Manager of Bioinformatics Division at Z-Tech, an ICFI company. He held a Research Scientist position at Sumitomo Chemical Company in Japan. He was a visiting scientist at National Cancer Institute (NCI) at National Institutes of Health (NIH). He was also an Associated Professor and the Director of Laboratory of Computational Chemistry at Nanjing University in China. He published more than 80 scientific papers and served as an Executive Editor or a member of Editorial Board of 9 peer-reviewed journals and as a reviewer of more than 20 peer-reviewed journals in the area of pharmacogenomics, proteomics, bioinformatics, and chemoinformatics. He received his Ph.D. from Nanjing University in China and did post-doctoral research at Maxwell Institute in Leeds University in England.

Research Interest

Genome-wide association studies (GWAS): baseline practices for analyzing GWAS data, technical robustness of genotyping technology, sources of spurious associations, batch effects in GWAS; Proteomics: quality control and quality assessment of proteomics data, biomarkers for detecting hepatotoxicity, prediction protein function from protein sequences; Genomics: development of classifiers of diagnosis and prognosis based on gene expression profiles.


Global Speakers in the subject

Global Experts in the subject


Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver
Lun Yang, Yan Li, Huixiao Hong, Ching-Wei Chang, Li-Wu Guo, Beverly Lyn-Cook, Leming Shi and Baitang Ning
Research Article: J Drug Metab Toxicol
DOI: 10.4172/2157-7609.1000119
Next-Generation Sequencing and Its Impact on Pharmacogenetics
Huixiao Hong
Editorial: J Pharmacogenomics Pharmacoproteomics 2012, 3:e119
DOI: 10.4172/2153-0645.1000e119
SELDI Based Proteomic Determination of Hepatic Biomarkers in Mouse Serum Following Acetaminophen Administration
Huixiao Hong, Candee Teitel, Laura P. James, Weida Tong, Jack A. Hinson, James C. Fuscoe, Yvonne Dragan
Research Article: J Proteomics Bioinform Vol.1.8 424-436 (2008)
DOI: 10.4172/jpb.1000051
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version